BRIAN PAYNE: Open Payments
NPI 1588896823 · OWENSBORO, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,442 in 96 payments from 18 companies in 2025. Trend: 2023 $1,561 · 2024 $2,385 · 2025 $1,442
Food & beverage: $1,442
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 29 | $312 |
| Amgen Inc. | 16 | $240 |
| AstraZeneca Pharmaceuticals LP | 10 | $221 |
| Lilly USA, LLC | 7 | $120 |
| ABBVIE INC. | 5 | $92 |
| Esperion Therapeutics, Inc. | 4 | $72 |
| Almatica Pharma LLC | 3 | $63 |
| Phathom Pharmaceuticals, Inc. | 7 | $60 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $56 |
| PFIZER INC. | 2 | $34 |
Products named: Wegovy, OTEZLA, MOUNJARO, Ozempic, EVENITY, NEXLETOL, UBRELVY, LOREEV XR.
Industry payments across KY — which companies pay providers there.
